Summary
AMETEK, Inc. (AME) demonstrated strong financial performance in 2018, achieving record backlog, orders, sales, operating income, net income, and diluted earnings per share. The company's growth was driven by a combination of 7% organic sales growth, strategic acquisitions, and successful implementation of its Operational Excellence initiatives. The company expanded its operations through six strategic acquisitions in 2018, investing over $1.1 billion. These acquisitions are expected to enhance AMETEK's market position and product offerings. Financially, AMETEK reported sales of $4.85 billion and diluted EPS of $3.34, representing increases of 13% and 13.6% respectively, over 2017. The company also strengthened its financial flexibility by amending its credit agreement to a $1.5 billion revolving credit facility and completing a $575 million private placement. AMETEK's strategy focuses on four key pillars: Operational Excellence, Strategic Acquisitions, Global & Market Expansion, and New Products. This approach, coupled with a diversified product portfolio across its Electronic Instruments (EIG) and Electromechanical (EMG) groups, positions the company well for continued growth. Investors can look to AMETEK's consistent investment in R&D and its track record of integrating acquisitions as positive indicators for future performance.
Financial Highlights
56 data points| Revenue | $4.85B |
| Cost of Revenue | $3.19B |
| Gross Profit | $1.66B |
| R&D Expenses | $141.00M |
| SG&A Expenses | $584.02M |
| Operating Expenses | $3.77B |
| Operating Income | $1.08B |
| Interest Expense | $82.18M |
| Net Income | $777.93M |
| EPS (Basic) | $3.37 |
| EPS (Diluted) | $3.34 |
| Shares Outstanding (Basic) | 230.82M |
| Shares Outstanding (Diluted) | 232.71M |
Key Highlights
- 1Record financial performance in 2018, including sales of $4.85 billion and diluted EPS of $3.34.
- 2Achieved 7% organic sales growth, supported by strong order intake and a growing backlog of $1.6 billion.
- 3Completed six strategic acquisitions in 2018, investing over $1.1 billion to expand market reach and product capabilities.
- 4Strengthened financial position by amending its credit facility to a $1.5 billion revolving credit line, maturing in October 2023.
- 5Continued investment in R&D, with $230.2 million spent in 2018, contributing to a significant portion of sales (24.7%) from new products launched in the last three years.
- 6Maintained operational efficiency and cost management through its 'Operational Excellence' initiatives.
- 7Diversified revenue streams across two main operating groups: Electronic Instruments (EIG) and Electromechanical (EMG), serving various end markets like aerospace, defense, medical, and industrial.